SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Oscient Pharmaceuticals Corp. (OSCI)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: John B. Anderson who wrote (54)8/23/1996 11:22:00 PM
From: Tara Cobble   of 1154
 
John you asked several questions:
>>>"Is the stock analyst at Oppenheimer who follows the stock Matt Geller? If so, I do know Matt and will check GENE out with him."<<<
Yes the report was written by Matthew M. Geller and Sharon R. Seiler.

>>>"Was GENE called Collaborative Research in '82? If so, the company has evolved substantially since that time!"<<<
Yes the company was founded in 1961 as Collaborative Research, Inc. (changed name in Sept. 1994 to more accurately reflect the company focus. (Merrill Lynch had initial public offering in 1982.)

GENE is headquartered in Waltham Mass. and employs 140 or more people. Oppenheimer and Co., Inc. was the sole manager for a directed institutional public offering of common stock in February 1996 at $13/share. At the time of the March report, GENE insiders owned 20% and institutions owned approximately 38%. GENE after the offering had and still has a lot of cash and is making a profit.

The report from Matt is very good and with a buy recommendation. The broker that I deal with has been following GENE for quite some time and has been bullish since my first purchase in mid 1995.

I do not know if Merrill Lynch follows the stock via an analyst.

Hope this information helps and let us know what Matt tells you. Tara

Several questions for you:
1) My broker is also expecting more and continued good news with GENE and pharmaceutical alliances, see what Matt has to say.
2) Do you know anything about or follow Aronex Pharmaceuticals Inc.(ARNX)? My broker has been bullish on this stock also and it has been moving up nicely upon expectations of upcoming good news on quite a few products that have been in the works.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News